This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four-fold to five-fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South-Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics-based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades.

中文翻译：

---

2022 年全球癌症统计数据：GLOBOCAN 对全球 185 个国家 36 种癌症的发病率和死亡率的估计


本文根据国际癌症研究机构 (IARC) 的最新估计，介绍了 2022 年世界各地区的全球癌症统计数据。 2022 年，将有近 2000 万新发癌症病例（包括非黑色素瘤皮肤癌 [NMSC]），同时有 970 万人死于癌症（包括 NMSC）。据估计，大约五分之一的男性或女性一生中会患上癌症，而大约九分之一的男性和十二分之一的女性会死于癌症。肺癌是 2022 年最常诊断出的癌症，导致近 250 万新发病例，即全球八分之一的癌症（占全球所有癌症的 12.4%），其次是女性乳腺癌（11.6%）、结直肠癌（9.6%） ）、前列腺（7.3%）和胃（4.9%）。肺癌也是癌症死亡的主要原因，估计有 180 万人死亡 (18.7%)，其次是结直肠癌 (9.3%)、肝癌 (7.8%)、女性乳腺癌 (6.9%) 和胃癌 (6.8%) 。乳腺癌和肺癌分别是女性和男性中最常见的癌症（无论是病例数还是死亡数）。世界各地区的发病率（包括 NMSC）从四倍到五倍不等，男性的发病率从澳大利亚/新西兰的 500 多例（每 10 万人中 507.9 例）到西非的不到 100 例（每 10 万人中 97.1 例），男性的发病率超过 400 例。澳大利亚/新西兰的女性（每 10 万人中有 410.5 人）到中南亚的女性接近 100 人（每 10 万人中有 103.3 人）。作者研究了世界 20 个地区 10 种主​​要癌症类型的地理变异性，讨论了最新趋势、潜在的决定因素以及全球癌症预防和控制的前景。 基于人口统计的预测表明，到 2050 年，新发癌症病例数将达到 3500 万，对预防的投资，包括针对癌症的关键风险因素（包括吸烟、超重和肥胖以及感染），可以避免数百万人的死亡。未来的癌症诊断并挽救全世界许多人的生命，在未来几十年为各国带来巨大的经济和社会红利。